Similar Papers

Paper Title
Journal
Date
Author
A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES. Report from the American Society of Hematology (ASH) Annual Meeting, December 9–12, 2023
-
memo - Magazine of European Medical Oncology | VOL. 16
--
01 Dec 2023
A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES. Report from the American Society of Hematology (ASH) Annual Meeting, December 11–14, 2021
-
memo - Magazine of European Medical Oncology | VOL. 15
--
01 Mar 2022
A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES Report from the American Society of Hematology (ASH) Annual Meeting, December 7–10, 2024
-
memo - Magazine of European Medical Oncology | VOL. -
--
21 Jan 2025
Advanced Practice Providers (APPs) in Hematology: Work Practices, Interactions with Physicians, and Opportunities for Collaboration within the American Society of Hematology (ASH)
Leah E Masselink ... Ariela L Marshall
Blood | VOL. 140
Leah E Masselink, et. al.Leah E Masselink ... Ariela L Marshall
15 Nov 2022
View more papers

More From: memo - Magazine of European Medical Oncology

Paper Title
Journal
Date
Author
ASCO highlights: neoadjuvant immunotherapy in mismatch repair deficient colorectal cancer
Gudrun Piringer
memo - Magazine of European Medical Oncology | VOL. -
Gudrun PiringerGudrun Piringer
31 Jan 2025
Biomarkers and treatment updates in renal cell carcinoma
Jasmin Alija Spiegelberg
memo - Magazine of European Medical Oncology | VOL. -
Jasmin Alija SpiegelbergJasmin Alija Spiegelberg
30 Jan 2025
A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES Report from the American Society of Hematology (ASH) Annual Meeting, December 7–10, 2024
-
memo - Magazine of European Medical Oncology | VOL. -
--
21 Jan 2025
Oligometastatic breast cancer from the perspective of the radiation oncologist
Stefan Konrad
memo - Magazine of European Medical Oncology | VOL. -
Stefan KonradStefan Konrad
16 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.